Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Bacterial Vaginosis Market Grown from 2024 to 2025?

The market size for bacterial vaginosis has experienced significant growth in the past few years. It is projected to increase from $3.03 billion in 2024 to $3.32 billion in 2025, registering a compound annual growth rate (CAGR) of 9.7%. The historical growth can be credited to factors such as the escalated adoption of point-of-care diagnostics, the expansion of e-commerce, an increase in risky sexual behaviors, growth in STI vaccination rates, and improved access to healthcare services.

What Growth Rate Is Anticipated for the Bacterial Vaginosis Market in the Coming Years?

In the subsequent years, the bacterial vaginosis market size is predicted to experience considerable growth. The market is projected to expand to $4.75 billion by 2029, with a compounded annual growth rate (CAGR) of 9.4%. This growth during the forecast period can be ascribed to factors such as heightened occurrence of bacterial vaginosis, an increasing demand for functional foods, a higher occurrence of STIs, a growing prevalence of health conditions in women, and increased understanding of menopause. Key trends during this forecast period encompass the incorporation of artificial intelligence in diagnostics, the use of probiotics, progress in STI testing at home, and the involvement of eco-friendly materials in women’s health devices.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21110&type=smp

Who Are the Leading Companies in the Bacterial Vaginosis Market?

Major companies operating in the bacterial vaginosis market are Pfizer Inc., Merck & Co. Inc., Merck KGaA, Bayer AG, Sanofi SA, Thermo Fisher Scientific, Becton Dickinson, Viatris Inc., Otsuka Pharmaceutical, LabCorp, Quest Diagnostics, Organon & Co., UT Southwestern Medical Center, Hologic Inc., bioMérieux SA, Shionogi & Company Limited, Melinta Therapeutics Inc., Evofem Biosciences, Gedea Biotech, Fleurstat, Medical Diagnostic Laboratories

What Are the Key Drivers of the Bacterial Vaginosis Market?

The surge in cases of sexually transmitted infections (STIs) is anticipated to propel the expansion of the bacterial vaginosis market. STIs are infections predominantly passed through sexual encounters and can be contracted from bacteria, viruses, or parasites. A rise in STIs is contributed by factors such as engaging in unprotected sex, having multiple partners, a lack of awareness, and resistance to antibiotics. Bacterial vaginosis poses a greater risk for STIs as it disrupts the balance of bacteria in the vagina, thereby facilitating infections like HIV and chlamydia. For instance, the European Centre for Disease Prevention and Control (ECDC), a governmental agency based in Sweden, reported in March 2024 that there was a significant increase in STI cases in 2022. Gonorrhea increased by 48%, syphilis by 34%, and chlamydia by 16%, compared to the previous year. Thus, the escalating cases of STIs are fostering the progression of the bacterial vaginosis market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=21110&type=smp

What Are the Key Market Segments in the Bacterial Vaginosis Industry?

The bacterial vaginosis market covered in this report is segmented –

1) By Type: Point-Of-Care Testing, Laboratory Testing, Other Types

2) By Product: Below 15 Years, Between 15-45, Other Products

3) By Application: Antibiotics, Other Applications

4) By End-User: Hospitals, Homecare, Specialty Clinics, Other End Users

Subsegments:

1) By Point-Of-Care Testing: Rapid Diagnostic Tests, Microscopy-based Tests, Immunoassays

2) By Laboratory Testing: Gram Staining, Polymerase Chain Reaction (PCR), DNA Probe Tests, Culture-based Testing

3) By Other Types: Home Testing Kits, Enzyme-linked Immunosorbent Assay (ELISA)

What Are the Latest Trends in the Bacterial Vaginosis Market?

Leading enterprises in the bacterial vaginosis market are focusing their efforts on creating inventive solutions like multiplexed polymerase chain reaction (PCR) tests, with the goal of improving the efficiency of diagnosis and treatment. A multiplexed PCR test is a specific type of PCR test that enables the simultaneous expansion and identification of multiple DNA or RNA target sequences within a single PCR procedure. For example, Cepheid, a biotechnology research firm from the U.S., launched the Xpert Xpress Multiplex Vaginal Panel (MVP) in November 2022. This panel can provide quick results in less than 60 minutes and identify three vaginal infections—bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and trichomoniasis (TV)—from a single patient sample. Moreover, the panel caters to both self-collected and clinician-collected swabs and uses automated real-time PCR technology to increase diagnostic precision and enhance women’s treatment outcomes. This highly adaptable panel can be used in a range of clinical environments, ensuring the accurate and effective detection of vaginal infections.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/bacterial-vaginosis-global-market-report

What Are the Key Regional Markets in the Bacterial Vaginosis Industry?

North America was the largest region in the bacterial vaginosis market in 2024. The regions covered in the bacterial vaginosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21110

This Report Delivers Insight On:

1. How big is the bacterial vaginosis market, and how is it changing globally?

2. Who are the major companies in the bacterial vaginosis market, and how are they performing?

3. What are the key opportunities and risks in the bacterial vaginosis market right now?

4. Which products or customer segments are growing the most in the bacterial vaginosis market?

5. What factors are helping or slowing down the growth of the bacterial vaginosis market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model